Symbols / MRAI
MRAI Chart
About
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 13.95M |
| Enterprise Value | 43.03M | Income | -12.09M | Sales | 20.70M |
| Book/sh | -1.81 | Cash/sh | 0.02 | Dividend Yield | — |
| Payout | 0.00% | Employees | 117 | IPO | — |
| P/E | — | Forward P/E | -1.54 | PEG | — |
| P/S | 0.67 | P/B | -0.32 | P/C | — |
| EV/EBITDA | -4.29 | EV/Sales | 2.08 | Quick Ratio | 0.07 |
| Current Ratio | 0.53 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -2.92 | EPS next Y | -0.38 | EPS Growth | — |
| Revenue Growth | -42.40% | Earnings | 2026-03-25 | ROA | -41.20% |
| ROE | — | ROIC | — | Gross Margin | 30.71% |
| Oper. Margin | -68.64% | Profit Margin | -58.40% | Shs Outstand | 23.88M |
| Shs Float | 13.50M | Short Float | 0.24% | Short Ratio | 0.11 |
| Short Interest | — | 52W High | 1.78 | 52W Low | 0.34 |
| Beta | 4.65 | Avg Volume | 42.51K | Volume | 38.64K |
| Target Price | — | Recom | None | Prev Close | $0.53 |
| Price | $0.58 | Change | 11.03% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.59
Latest analyst target
3. DCF / Fair value
$-2.65
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.59
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-03-28 | up | Maxim Group | Hold → Buy | $6 |
| 2023-11-15 | down | Maxim Group | Buy → Hold | — |
| 2023-11-14 | down | Maxim Group | Buy → Hold | — |
- Health tech firm Marpai lands 19,000 workers for its drug-benefit platform - Stock Titan Mon, 23 Feb 2026 13
- Marpai director Pons buys $50,000 in MRAI stock - Investing.com Wed, 12 Nov 2025 08
- Insider Purchase: Director at $MRAI Buys 100,000 Shares - Quiver Quantitative Wed, 12 Nov 2025 08
- Marpai Secures Insider Promissory Note for Working Capital - TipRanks Fri, 13 Feb 2026 08
- Marpai consolidates leadership as CEO Damien Lamendola becomes President - The Globe and Mail Sat, 24 Jan 2026 08
- Marpai (OTCQX: MRAI) renews Aetna ASA pact, adds Faircost Optimizer tool - Stock Titan Mon, 01 Dec 2025 08
- Marpai Appoints Dallas Scrip as New President - The Globe and Mail Sat, 30 Aug 2025 07
- Earnings call transcript: Marpai Q3 2025 sees EPS miss, stock drops 20% - Investing.com hu, 13 Nov 2025 08
- MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION - ChartMill Mon, 01 Dec 2025 08
- MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND - PR Newswire Mon, 06 Oct 2025 07
- 13 Penny Stocks with Insider Buying in 2024 - Yahoo Finance Sun, 12 May 2024 07
- The 5 Hottest CEO Stock Purchases So Far This Year - MarketBeat Mon, 08 Apr 2024 07
- Will Marpai Stock Surge For Second Day? - RTTNews Fri, 14 Apr 2023 07
- Earnings call transcript: Marpai Q2 2025 shows improved loss but revenue decline - Investing.com South Africa hu, 14 Aug 2025 07
- Why Is Aravive (ARAV) Stock Down 52% Today? - InvestorPlace hu, 18 Jan 2024 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 100000 | 141500 | — | Purchase at price 1.42 per share. | EITAN YARON I | Director | — | 2025-11-07 00:00:00 | D |
| 1 | 50000 | 70750 | — | Purchase at price 1.42 per share. | PONS ROBERT M | Director | — | 2025-11-07 00:00:00 | D |
| 2 | 50000 | 70750 | — | Purchase at price 1.42 per share. | SHIV SAGIV | Director | — | 2025-11-07 00:00:00 | D |
| 3 | 100000 | 141500 | — | Stock Award(Grant) at price 1.42 per share. | SCRIP DALLAS | Chief Operating Officer | — | 2025-11-07 00:00:00 | I |
| 4 | 125000 | — | — | Stock Award(Grant) at price 0.00 per share. | EITAN YARON I | Director | — | 2025-10-20 00:00:00 | D |
| 5 | 75000 | — | — | Stock Award(Grant) at price 0.00 per share. | SHIV SAGIV | Director | — | 2025-10-20 00:00:00 | D |
| 6 | 50000 | — | — | Stock Award(Grant) at price 0.00 per share. | CALABRESE JENNIFER ROSARIO | Director | — | 2025-10-20 00:00:00 | D |
| 7 | 550000 | — | — | Stock Award(Grant) at price 0.00 per share. | LAMENDOLA DAMIEN | Chief Executive Officer | — | 2025-10-20 00:00:00 | D |
| 8 | 275000 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSON STEVE ANDREW | Chief Financial Officer | — | 2025-10-20 00:00:00 | D |
| 9 | 188000 | 270640 | — | Sale at price 1.40 - 1.63 per share. | INTELLIGENT FANATICS CAPITAL MANAGEMENT LLC | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-06 00:00:00 | I |
Financials
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | -16.31K | -5.20K | -170.30 |
| TaxRateForCalcs | 0.01 | 0.02 | 0.01 |
| NormalizedEBITDA | -20.49M | -22.31M | -13.63M |
| TotalUnusualItems | -1.63M | -273.79K | -18.92K |
| TotalUnusualItemsExcludingGoodwill | -1.63M | -273.79K | -18.92K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -28.75M | -26.47M | -15.98M |
| ReconciledDepreciation | 5.40M | 4.14M | 2.06M |
| ReconciledCostOfRevenue | 22.74M | 16.54M | 10.19M |
| EBITDA | -22.12M | -22.59M | -13.65M |
| EBIT | -27.51M | -26.72M | -15.71M |
| NetInterestIncome | -1.53M | -266.78K | -427.18K |
| InterestExpense | 1.53M | 266.78K | 427.18K |
| NormalizedIncome | -27.14M | -26.20M | -15.97M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -28.75M | -26.47M | -15.98M |
| TotalExpenses | 63.53M | 51.03M | 30.09M |
| TotalOperatingIncomeAsReported | -27.98M | -26.96M | -15.86M |
| DilutedAverageShares | 6.95M | 5.06M | 2.52M |
| BasicAverageShares | 6.95M | 5.06M | 2.52M |
| DilutedEPS | -4.14 | -5.24 | -6.36 |
| BasicEPS | -4.14 | -5.24 | -6.36 |
| DilutedNIAvailtoComStockholders | -28.75M | -26.47M | -15.98M |
| NetIncomeCommonStockholders | -28.75M | -26.47M | -15.98M |
| NetIncome | -28.75M | -26.47M | -15.98M |
| NetIncomeIncludingNoncontrollingInterests | -28.75M | -26.47M | -15.98M |
| NetIncomeContinuousOperations | -28.75M | -26.47M | -15.98M |
| TaxProvision | -290.14K | -521.13K | -150.00K |
| PretaxIncome | -29.04M | -26.99M | -16.13M |
| OtherIncomeExpense | -1.14M | -39.32K | 153.59K |
| OtherNonOperatingIncomeExpenses | 488.87K | 234.47K | 172.51K |
| SpecialIncomeCharges | -1.60M | -273.43K | 0.00 |
| GainOnSaleOfPPE | -335.11K | -273.43K | 0.00 |
| GainOnSaleOfBusiness | 1.75M | 0.00 | |
| ImpairmentOfCapitalAssets | 3.02M | 0.00 | |
| GainOnSaleOfSecurity | -26.48K | -361.00 | -18.92K |
| NetNonOperatingInterestIncomeExpense | -1.53M | -266.78K | -427.18K |
| InterestExpenseNonOperating | 1.53M | 266.78K | 427.18K |
| OperatingIncome | -26.37M | -26.68M | -15.86M |
| OperatingExpense | 39.29M | 33.89M | 19.80M |
| OtherOperatingExpenses | 8.31M | 7.39M | 3.08M |
| DepreciationAmortizationDepletionIncomeStatement | 3.90M | 3.54M | 1.96M |
| DepreciationAndAmortizationInIncomeStatement | 3.90M | 3.54M | 1.96M |
| ResearchAndDevelopment | 1.31M | 3.71M | 1.73M |
| SellingGeneralAndAdministration | 25.77M | 19.26M | 13.02M |
| SellingAndMarketingExpense | 6.60M | 6.94M | 4.97M |
| GeneralAndAdministrativeExpense | 19.18M | 12.32M | 8.06M |
| OtherGandA | 19.18M | 12.32M | 8.06M |
| GrossProfit | 12.92M | 7.21M | 3.94M |
| CostOfRevenue | 24.24M | 17.14M | 10.29M |
| TotalRevenue | 37.16M | 24.34M | 14.23M |
| OperatingRevenue | 37.16M | 24.34M | 14.23M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 7.96M | 5.32M | 5.07M |
| ShareIssued | 7.96M | 5.32M | 5.07M |
| TotalDebt | 4.20M | 6.08M | 2.09M |
| TangibleBookValue | -23.76M | -10.61M | 15.51M |
| InvestedCapital | -13.44M | 6.13M | 29.71M |
| WorkingCapital | -3.76M | 9.18M | 15.85M |
| NetTangibleAssets | -23.76M | -10.61M | 15.51M |
| CapitalLeaseObligations | 4.20M | 6.08M | 2.09M |
| CommonStockEquity | -13.44M | 6.13M | 29.71M |
| TotalCapitalization | -13.44M | 6.13M | 29.71M |
| TotalEquityGrossMinorityInterest | -13.44M | 6.13M | 29.71M |
| StockholdersEquity | -13.44M | 6.13M | 29.71M |
| RetainedEarnings | -76.75M | -47.99M | -21.53M |
| AdditionalPaidInCapital | 63.31M | 54.13M | 51.23M |
| CapitalStock | 796.00 | 532.00 | 2.03K |
| CommonStock | 796.00 | 532.00 | 2.03K |
| TotalLiabilitiesNetMinorityInterest | 45.12M | 43.82M | 14.49M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 24.27M | 26.46M | 3.35M |
| OtherNonCurrentLiabilities | 19.40M | 20.20M | 45.00K |
| NonCurrentDeferredLiabilities | 1.19M | 1.48M | 2.00M |
| NonCurrentDeferredTaxesLiabilities | 1.19M | 1.48M | 2.00M |
| LongTermDebtAndCapitalLeaseObligation | 3.68M | 4.77M | 1.30M |
| LongTermCapitalLeaseObligation | 3.68M | 4.77M | 1.30M |
| CurrentLiabilities | 20.84M | 17.36M | 11.15M |
| OtherCurrentLiabilities | 631.58K | 244.03K | 418.99K |
| CurrentDeferredLiabilities | 660.83K | 288.50K | 1.17M |
| CurrentDeferredRevenue | 660.83K | 288.50K | 1.17M |
| CurrentDebtAndCapitalLeaseObligation | 512.42K | 1.31M | 784.49K |
| CurrentCapitalLeaseObligation | 512.42K | 1.31M | 784.49K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 1.20M | 1.43M | 897.29K |
| PayablesAndAccruedExpenses | 17.84M | 14.33M | 8.30M |
| CurrentAccruedExpenses | 13.19M | 12.87M | 7.17M |
| Payables | 4.65M | 1.46M | 1.13M |
| DuetoRelatedPartiesCurrent | 0.00 | 3.20K | 3.64K |
| AccountsPayable | 4.65M | 1.46M | 1.13M |
| TotalAssets | 31.68M | 49.95M | 44.20M |
| TotalNonCurrentAssets | 14.59M | 23.41M | 17.21M |
| OtherNonCurrentAssets | 21.67K | 21.67K | 28.33K |
| NonCurrentPrepaidAssets | 1.27M | 1.29M | 52.28K |
| GoodwillAndOtherIntangibleAssets | 10.32M | 16.75M | 14.20M |
| OtherIntangibleAssets | 7.30M | 10.91M | 11.81M |
| Goodwill | 3.02M | 5.84M | 2.38M |
| NetPPE | 2.98M | 5.35M | 2.93M |
| AccumulatedDepreciation | -150.90K | -649.75K | -295.58K |
| GrossPPE | 3.13M | 6.00M | 3.23M |
| Leases | 0.00 | 745.45K | 621.53K |
| OtherProperties | 2.51M | 4.24M | 2.27M |
| MachineryFurnitureEquipment | 620.87K | 1.01M | 341.77K |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 17.08M | 26.54M | 26.99M |
| OtherCurrentAssets | 891.53K | 1.60M | 743.13K |
| RestrictedCash | 12.34M | 9.35M | 6.75M |
| PrepaidAssets | 743.13K | ||
| Receivables | 2.70M | 1.82M | 315.24K |
| OtherReceivables | 1.58M | 381.03K | 106.48K |
| AccountsReceivable | 1.13M | 1.44M | 208.76K |
| AllowanceForDoubtfulAccountsReceivable | -24.62K | -23.46K | 0.00 |
| GrossAccountsReceivable | 1.15M | 1.46M | 208.76K |
| CashCashEquivalentsAndShortTermInvestments | 1.15M | 13.76M | 19.18M |
| CashAndCashEquivalents | 1.15M | 13.76M | 19.18M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| FreeCashFlow | -15.75M | -36.20M | -12.54M |
| RepaymentOfDebt | 0.00 | -3.78M | |
| IssuanceOfDebt | 0.00 | 3.55M | |
| IssuanceOfCapitalStock | 6.73M | 0.00 | 25.38M |
| CapitalExpenditure | -965.57K | -1.74M | |
| EndCashPosition | 13.49M | 23.12M | 25.93M |
| BeginningCashPosition | 23.12M | 25.93M | 1.82M |
| ChangesInCash | -9.63M | -2.82M | 24.12M |
| FinancingCashFlow | 5.10M | 196.00 | 25.27M |
| CashFlowFromContinuingFinancingActivities | 5.10M | 196.00 | 25.27M |
| NetOtherFinancingCharges | -1.66M | -831.58K | |
| ProceedsFromStockOptionExercised | 32.62K | 196.00 | 953.39K |
| NetCommonStockIssuance | 6.73M | 0.00 | 25.38M |
| CommonStockIssuance | 6.73M | 0.00 | 25.38M |
| NetIssuancePaymentsOfDebt | 0.00 | -233.26K | |
| NetShortTermDebtIssuance | 0.00 | 0.00 | |
| ShortTermDebtPayments | 0.00 | -3.00M | |
| ShortTermDebtIssuance | 0.00 | 3.00M | |
| NetLongTermDebtIssuance | 0.00 | -233.26K | |
| LongTermDebtPayments | 0.00 | -783.26K | |
| LongTermDebtIssuance | 0.00 | 550.00K | |
| InvestingCashFlow | 1.03M | 32.42M | 9.64M |
| CashFlowFromContinuingInvestingActivities | 1.03M | 32.42M | 9.64M |
| NetOtherInvestingChanges | 33.39M | 11.38M | |
| NetBusinessPurchaseAndSale | 1.00M | 0.00 | |
| SaleOfBusiness | 1.00M | 0.00 | |
| NetIntangiblesPurchaseAndSale | 0.00 | -3.05K | |
| PurchaseOfIntangibles | 0.00 | -3.05K | |
| NetPPEPurchaseAndSale | 26.91K | -362.77K | -273.43K |
| SaleOfPPE | 26.91K | 0.00 | 0.00 |
| PurchaseOfPPE | 0.00 | -362.77K | -273.43K |
| CapitalExpenditureReported | 0.00 | -602.80K | -1.46M |
| OperatingCashFlow | -15.75M | -35.24M | -10.80M |
| CashFlowFromContinuingOperatingActivities | -15.75M | -35.24M | -10.80M |
| ChangeInWorkingCapital | 2.34M | -16.06M | 1.58M |
| ChangeInOtherCurrentLiabilities | -1.55M | -1.73M | -139.86K |
| ChangeInOtherCurrentAssets | 0.00 | 6.67K | -28.33K |
| ChangeInPayablesAndAccruedExpense | 3.24M | -14.70M | 2.22M |
| ChangeInAccruedExpense | 51.47K | -14.88M | 2.43M |
| ChangeInPayable | 3.19M | 178.63K | -214.60K |
| ChangeInAccountPayable | 3.19M | 181.44K | 25.41K |
| ChangeInPrepaidAssets | 736.93K | 892.58K | -346.91K |
| ChangeInReceivables | -83.23K | -536.19K | -122.97K |
| ChangesInAccountReceivables | -105.35K | -597.05K | -131.51K |
| OtherNonCashItems | 1.61M | 297.41K | 467.61K |
| StockBasedCompensation | 2.10M | 3.11M | 1.23M |
| AssetImpairmentCharge | 3.02M | 0.00 | |
| DeferredTax | -290.14K | -521.13K | -150.00K |
| DeferredIncomeTax | -290.14K | -521.13K | -150.00K |
| DepreciationAmortizationDepletion | 5.40M | 4.14M | 2.06M |
| DepreciationAndAmortization | 5.40M | 4.14M | 2.06M |
| AmortizationCashFlow | 3.56M | 3.14M | |
| AmortizationOfIntangibles | 3.56M | 3.14M | |
| Depreciation | 1.84M | 996.39K | 2.06M |
| OperatingGainsLosses | -1.17M | 273.43K | |
| GainLossOnInvestmentSecurities | 241.55K | ||
| GainLossOnSaleOfBusiness | -1.75M | 0.00 | |
| NetIncomeFromContinuingOperations | -28.75M | -26.47M | -15.98M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for MRAI
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|